15% OFF Follistatin 344 – 1mg/vial (Research Use Only)
Myostatin (GDF-8) inhibitor. Binds and neutralizes myostatin, the primary negative regulator of skeletal muscle mass. Studied in muscle-mass and body-composition research. Research use only.
Availability: In stock
3–4 vials — 5% off · 5–9 vials — 10% off · 10+ vials — 15% off
Applied automatically in the cart. Combines with a discount code up to 20% off in total, and stacks on top of the subscription discount.
Research Disclaimer: All products currently listed on this site are for research purposes only.
Overview
Follistatin-344 is a naturally occurring isoform of follistatin, a secreted glycoprotein encoded by the FST gene that functions as a potent endogenous antagonist of myostatin (GDF-8) and other TGF-β superfamily members. By binding and neutralizing myostatin — the primary negative regulator of skeletal muscle mass — follistatin-344 has generated substantial published research interest in muscle biology, body composition research, and reproductive endocrinology.
What It Is
Follistatin-344 is the 344-amino acid heparin-binding isoform of human follistatin, produced by alternative mRNA splicing of the FST gene. MW approximately 37–45 kDa (glycoprotein). It contains three follistatin domain (FSD) repeats that enable tight non-covalent binding to activin A, myostatin (GDF-8), GDF-11, and other TGF-β ligands, effectively sequestering them from their receptors.
Key Research Applications
- Myostatin (GDF-8) binding and neutralization mechanism research
- Skeletal muscle hypertrophy signaling, satellite cell activation, and myogenesis studies
- TGF-β superfamily member antagonism (activin A, GDF-11, BMP) pathway research
- Follistatin isoform (FS-288, FS-315, FS-344) comparative binding and biological activity studies
- Reproductive axis research — FSH suppression, activin antagonism, and ovarian biology
- Muscle wasting disease modeling (cachexia, sarcopenia, muscular dystrophy preclinical models)
- Adipose tissue biology — myostatin/activin signaling in fat cell differentiation research
- Bone and cartilage biology — BMP-2/4/7 regulation and osteogenesis research
Technical Specifications
| Protein | Follistatin-344 (FST gene, isoform 344) |
| Amino Acids | 344 |
| Molecular Weight | ~37–45 kDa (glycoprotein) |
| Primary Target | Myostatin (GDF-8), Activin A, GDF-11 |
| Mechanism | TGF-β Superfamily Ligand Antagonist |
| Purity | ≥95% (supplier specification) |
| Form | Lyophilized powder |
| Vial Size | 1mg |
| Storage | −112 °F long-term; −4 °F short-term; avoid repeated freeze-thaw |
FOR RESEARCH USE ONLY. Not intended for human or veterinary consumption, medical diagnosis, treatment, or prevention of any disease or condition. This product has not been evaluated by the FDA or any regulatory agency. Must be handled by qualified research personnel in a compliant laboratory setting. These statements have not been evaluated by the Food and Drug Administration.
Not sure which compounds fit your research? Browse the Research Hub →
- Processing: Orders ship within 1–2 business days
- Domestic delivery: 3–5 business days via USPS Priority / UPS Ground
- Free shipping on orders over $100
- Temperature handling: Cold-chain packaging available on request for lyophilized peptides
- Tracking: Emailed automatically at time of dispatch
- Store lyophilized (dry) peptides at −4 °F for long-term stability
- Protect from light and moisture at all times
- Do not freeze
- Where the Storage row in the product specification above differs, follow the specification
Pairs Well With
Related research products
Reviews
There are no reviews yet.